{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T18:03:27Z","timestamp":1760551407383},"reference-count":75,"publisher":"Impact Journals, LLC","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2021,4,13]]},"DOI":"10.18632\/oncotarget.27934","type":"journal-article","created":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T20:11:35Z","timestamp":1617826295000},"page":"845-858","source":"Crossref","is-referenced-by-count":2,"title":["Predicting clinical outcomes using cancer progression associated signatures"],"prefix":"10.18632","volume":"12","author":[{"given":"Jared","family":"Mamrot","sequence":"first","affiliation":[{"name":"GMDx Group Ltd, Melbourne, Victoria, Australia"},{"name":"Department of Obstetrics and Gynaecology, Monash University, Clayton, VIC, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan E.","family":"Hall","sequence":"additional","affiliation":[{"name":"GMDx Group Ltd, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robyn A.","family":"Lindley","sequence":"additional","affiliation":[{"name":"GMDx Group Ltd, Melbourne, Victoria, Australia"},{"name":"Department of Clinical Pathology, The Victorian Comprehensive Cancer Centre, Faculty of Medicine, Dentistry & Health Sciences, University of Melbourne, VIC, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"6","author":"Jemal","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"2","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/ijc.31937","article-title":"Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods","volume":"14","author":"Bray","year":"2019","journal-title":"Int J Cancer"},{"key":"3","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/ijc.31664","article-title":"Global cancer incidence in older adults, 2012 and 2035: A population-based study: Global cancer incidence in older adults","volume":"14","author":"Soerjomataram","year":"2019","journal-title":"Int J Cancer"},{"key":"4","doi-asserted-by":"publisher","first-page":"574111","DOI":"10.3389\/fpubh.2020.574111","article-title":"Management and Prevention Strategies for Non-communicable Diseases (NCDs) and Their Risk Factors","volume":"8","author":"Kodzius","year":"2020","journal-title":"Front Public Health"},{"key":"5","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13073-016-0364-2","article-title":"Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT\/COMPACT trial","volume":"8","author":"Clarke","year":"2016","journal-title":"Genome Med"},{"key":"6","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/nm.4333","article-title":"Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients","volume":"2","author":"Schram","year":"2017","journal-title":"Nat Med"},{"key":"7","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/S1097-2765(02)00742-6","article-title":"RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators","volume":"1","author":"Neuberger","year":"2002","journal-title":"Mol Cell"},{"key":"8","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/ng.2701","article-title":"Evidence for APOBEC3B mutagenesis in multiple human cancers","volume":"4","author":"Harris","year":"2013","journal-title":"Nat Genet"},{"key":"9","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.jmb.2004.01.046","article-title":"Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes: correlation with mutation spectra in vivo","volume":"33","author":"Neuberger","year":"2004","journal-title":"J Mol Biol"},{"key":"10","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/ng.2702","article-title":"An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers","volume":"4","author":"Resnick","year":"2013","journal-title":"Nat Genet"},{"key":"11","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"50","author":"Butler","year":"2013","journal-title":"Nature"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.18103\/mra.v8i8.2177","article-title":"A Review of the mutational role of deaminases and the generation of a cognate molecular model to explain cancer mutation spectra","volume":"8","author":"Lindley","year":"2020","journal-title":"Med Res Arch"},{"key":"13","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.cancergen.2013.05.016","article-title":"The importance of codon context for understanding the Ig-like somatic hypermutation strand-biased patterns in TP53 mutations in breast cancer","volume":"20","author":"Lindley","year":"2013","journal-title":"Cancer Genet"},{"key":"14","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1002\/cam4.825","article-title":"Association between targeted somatic mutation (TSM) signatures and HGS-OvCa progression","volume":"5","author":"Pendlebury","year":"2016","journal-title":"Cancer Med"},{"key":"15","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1146\/annurev.biochem.71.110601.135501","article-title":"RNA editing by adenosine deaminases that act on RNA","volume":"7","author":"Bass","year":"2002","journal-title":"Annu Rev Biochem"},{"key":"16","doi-asserted-by":"publisher","first-page":"e0120089","DOI":"10.1371\/journal.pone.0120089","article-title":"APOBEC3A is implicated in a novel class of G-to-A mRNA editing in WT1 transcripts","volume":"1","author":"Bonnet","year":"2015","journal-title":"PLoS One"},{"key":"17","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nrm.2015.4","article-title":"A-to-I editing of coding and non-coding RNAs by ADARs","volume":"1","author":"Nishikura","year":"2016","journal-title":"Nat Rev Mol Cell Biol"},{"key":"18","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1093\/nar\/gkg464","article-title":"Human activation-induced cytidine deaminase causes transcription-dependent, strand-biased C to U deaminations","volume":"3","author":"Bhagwat","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev.biochem.76.061705.090740","article-title":"Molecular mechanisms of antibody somatic hypermutation","volume":"7","author":"Neuberger","year":"2007","journal-title":"Annu Rev Biochem"},{"key":"20","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.cell.2020.06.012","article-title":"Proteogenomics of Non-smoking Lung Cancer in East Asia Delineates Molecular Signatures of Pathogenesis and Progression","volume":"18","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"21","doi-asserted-by":"publisher","first-page":"102905","DOI":"10.1016\/j.dnarep.2020.102905","article-title":"Molecular origins of APOBEC-associated mutations in cancer","volume":"9","author":"Maciejowski","year":"2020","journal-title":"DNA Repair (Amst)"},{"key":"22","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/ng.3573","article-title":"Divergent modes of clonal spread and intraperitoneal mixing in high-grade serous ovarian cancer","volume":"4","author":"Smith","year":"2016","journal-title":"Nat Genet"},{"key":"23","doi-asserted-by":"publisher","first-page":"eaaw2872","DOI":"10.1126\/science.aaw2872","article-title":"Passenger hotspot mutations in cancer driven by APOBEC3A and mesoscale genomic features","volume":"36","author":"Lawrence","year":"2019","journal-title":"Science"},{"key":"24","doi-asserted-by":"publisher","first-page":"8866","DOI":"10.1038\/ncomms9866","article-title":"Whole-genome sequencing reveals activation-induced cytidine deaminase signatures during indolent chronic lymphocytic leukaemia evolution","volume":"6","author":"Lander","year":"2015","journal-title":"Nat Commun"},{"key":"25","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nm.4292","article-title":"HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures","volume":"2","author":"Raine","year":"2017","journal-title":"Nat Med"},{"key":"26","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.1038\/s41467-018-05058-y","article-title":"Genomic patterns of progression in smoldering multiple myeloma","volume":"9","author":"Fulciniti","year":"2018","journal-title":"Nat Commun"},{"key":"27","doi-asserted-by":"publisher","first-page":"3924","DOI":"10.1038\/s41388-018-0245-9","article-title":"APOBEC3B and APOBEC mutational signature as potential predictive markers for immunotherapy response in non-small cell lung cancer","volume":"3","author":"Liu","year":"2018","journal-title":"Oncogene"},{"key":"28","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1136\/gutjnl-2018-317601","article-title":"APOBEC3B interaction with PRC2 modulates microenvironment to promote HCC progression","volume":"6","author":"Yu","year":"2019","journal-title":"Gut"},{"key":"29","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1158\/2159-8290.CD-15-0344","article-title":"APOBEC Enzymes: Mutagenic Fuel for Cancer Evolution and Heterogeneity","volume":"5","author":"Harris","year":"2015","journal-title":"Cancer Discov"},{"key":"30","doi-asserted-by":"publisher","first-page":"e20200261","DOI":"10.1084\/jem.20200261","article-title":"APOBEC3A catalyzes mutation and drives carcinogenesis","volume":"21","author":"Stavrou","year":"2020","journal-title":"J Exp Med"},{"key":"31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.dnarep.2017.04.004","article-title":"ADAR deaminase A-to-I editing of DNA and RNA moieties of RNA:DNA hybrids has implications for the mechanism of Ig somatic hypermutation","volume":"5","author":"Lindley","year":"2017","journal-title":"DNA Repair (Amst)"},{"key":"32","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.mrfmmm.2018.03.008","article-title":"APOBEC and ADAR deaminases may cause many single nucleotide polymorphisms curated in the OMIM database","volume":"81","author":"Hall","year":"2018","journal-title":"Mutat Res"},{"key":"33","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.cell.2011.01.001","article-title":"The RNA exosome targets the AID cytidine deaminase to both strands of transcribed duplex DNA substrates","volume":"14","author":"Deng","year":"2011","journal-title":"Cell"},{"key":"34","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.1093\/nar\/gkx050","article-title":"DNA editing in DNA\/RNA hybrids by adenosine deaminases that act on RNA","volume":"4","author":"Beal","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"35","doi-asserted-by":"publisher","first-page":"e03258","DOI":"10.1016\/j.heliyon.2020.e03258","article-title":"A proposed reverse transcription mechanism for (CAG)n and similar expandable repeats that cause neurological and other diseases","volume":"6","author":"Lindley","year":"2020","journal-title":"Heliyon"},{"key":"36","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.semcancer.2017.08.010","article-title":"Prognostic and predictive biomarkers in breast cancer: Past, present and future","volume":"5","author":"Duffy","year":"2018","journal-title":"Semin Cancer Biol"},{"key":"37","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1002\/cncr.29038","article-title":"Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm\/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing assay","volume":"12","author":"Nikiforova","year":"2014","journal-title":"Cancer"},{"key":"38","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1056\/NEJMoa021967","article-title":"A gene-expression signature as a predictor of survival in breast cancer","volume":"34","author":"Witteveen","year":"2002","journal-title":"N Engl J Med"},{"key":"39","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1056\/NEJMoa1602253","article-title":"70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer","volume":"37","author":"Goulioti","year":"2016","journal-title":"N Engl J Med"},{"key":"40","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/s12885-020-06756-x","article-title":"Sequential analysis of transcript expression patterns improves survival prediction in multiple cancers","volume":"2","author":"Prochownik","year":"2020","journal-title":"BMC Cancer"},{"key":"41","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.molcel.2018.11.035","article-title":"SubCellBarCode: Proteome-wide Mapping of Protein Localization and Relocalization","volume":"7","author":"Lehti\u00f6","year":"2019","journal-title":"Mol Cell"},{"key":"42","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s42003-019-0736-4","article-title":"Diversity spectrum analysis identifies mutation-specific effects of cancer driver genes","volume":"3","author":"Jun Li","year":"2020","journal-title":"Commun Biol"},{"key":"43","doi-asserted-by":"publisher","first-page":"6195","DOI":"10.1038\/s41467-020-19971-8","article-title":"Common germline-somatic variant interactions in advanced urothelial cancer","volume":"1","author":"Robinson","year":"2020","journal-title":"Nat Commun"},{"key":"44","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/s41586-019-1651-z","article-title":"The U1 spliceosomal RNA is recurrently mutated in multiple cancers","volume":"57","author":"Stein","year":"2019","journal-title":"Nature"},{"key":"45","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/s41588-018-0318-2","article-title":"Molecular landmarks of tumor hypoxia across cancer types","volume":"5","author":"Yousif","year":"2019","journal-title":"Nat Genet"},{"key":"46","doi-asserted-by":"publisher","first-page":"e0233678","DOI":"10.1371\/journal.pone.0233678","article-title":"Deep learning-based survival prediction for multiple cancer types using histopathology images","volume":"1","author":"Stumpe","year":"2020","journal-title":"PLoS One"},{"key":"47","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.dnarep.2017.03.003","article-title":"APOBEC3B cytidine deaminase targets the non-transcribed strand of tRNA genes in yeast","volume":"5","author":"Gordenin","year":"2017","journal-title":"DNA Repair (Amst)"},{"key":"48","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.molimm.2008.10.021","article-title":"Mechanism of somatic hypermutation: critical analysis of strand biased mutation signatures at A:T and G:C base pairs","volume":"4","author":"Steele","year":"2009","journal-title":"Mol Immunol"},{"key":"49","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/j.molimm.2003.11.026","article-title":"Analysis of strand biased \u2018G\u2019.C hypermutation in human immunoglobulin V(\u03bb) gene segments suggests that both DNA strands are targets for deamination by activation-induced cytidine deaminase","volume":"4","author":"Spencer","year":"2004","journal-title":"Mol Immunol"},{"key":"50","doi-asserted-by":"publisher","first-page":"9245","DOI":"10.1096\/fj.201903036RR","article-title":"Activation-induced cytidine deaminase can target multiple topologies of double-stranded DNA in a transcription-independent manner","volume":"3","author":"Larijani","year":"2020","journal-title":"FASEB J"},{"key":"51","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1038\/ng.3441","article-title":"Clock-like mutational processes in human somatic cells","volume":"4","author":"Stratton","year":"2015","journal-title":"Nat Genet"},{"key":"52","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","article-title":"The repertoire of mutational signatures in human cancer","volume":"57","author":"Klimczak","year":"2020","journal-title":"Nature"},{"key":"53","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nature08658","article-title":"A comprehensive catalogue of somatic mutations from a human cancer genome","volume":"46","author":"Bauer","year":"2010","journal-title":"Nature"},{"key":"54","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/bjc.2017.133","article-title":"Elevated APOBEC3B expression drives a kataegic-like mutation signature and replication stress-related therapeutic vulnerabilities in p53-defective cells","volume":"11","author":"Pettitt","year":"2017","journal-title":"Br J Cancer"},{"key":"55","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1001\/jamaoncol.2019.0626","article-title":"Tumor Mutation Burden-From Hopes to Doubts","volume":"5","author":"Weiss","year":"2019","journal-title":"JAMA Oncol"},{"key":"56","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12885-020-6658-1","article-title":"Tumor mutational burden is associated with poor outcomes in diffuse glioma","volume":"2","author":"Luo","year":"2020","journal-title":"BMC Cancer"},{"key":"57","doi-asserted-by":"publisher","first-page":"e28338","DOI":"10.1002\/pbc.28338","article-title":"Tumor mutational burden and driver mutations: characterizing the genomic landscape of pediatric brain tumors","volume":"6","author":"Weintraub","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"58","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.2217\/fon-2020-0047","article-title":"Predictive markers of immune response in glioblastoma: hopes and facts","volume":"1","author":"Brandes","year":"2020","journal-title":"Future Oncol"},{"key":"59","doi-asserted-by":"publisher","first-page":"a042","DOI":"10.1093\/noajnl\/vdaa042","article-title":"Tumor mutational burden predicts survival in patients with low-grade gliomas expressing mutated IDH1","volume":"2","author":"Lowenstein","year":"2020","journal-title":"Neurooncol Adv"},{"key":"60","doi-asserted-by":"crossref","unstructured":"Chen, Guestrin. XGBoost: A Scalable Tree Boosting System. Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining. San Francisco California USA: ACM. 2016; 785-94. https:\/\/doi.org\/10.1145\/2939672.2939785.","DOI":"10.1145\/2939672.2939785"},{"key":"61","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nature12625","article-title":"The causes and consequences of genetic heterogeneity in cancer evolution","volume":"50","author":"Swanton","year":"2013","journal-title":"Nature"},{"key":"62","doi-asserted-by":"publisher","first-page":"4437","DOI":"10.1038\/s41467-020-18290-2","article-title":"The trajectory of intrahelical lesion recognition and extrusion by the human 8-oxoguanine DNA glycosylase","volume":"1","author":"Verdine","year":"2020","journal-title":"Nat Commun"},{"key":"63","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/349431a0","article-title":"Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG","volume":"34","author":"Grollman","year":"1991","journal-title":"Nature"},{"key":"64","doi-asserted-by":"publisher","first-page":"102673","DOI":"10.1016\/j.dnarep.2019.102673","article-title":"Inflammation-induced DNA damage, mutations and cancer","volume":"8","author":"Engelward","year":"2019","journal-title":"DNA Repair (Amst)"},{"key":"65","doi-asserted-by":"publisher","first-page":"e12760","DOI":"10.1111\/sji.12760","article-title":"Molecular model linking Th2 polarized M2 tumour-associated macrophages with deaminase-mediated cancer progression mutation signatures","volume":"8","author":"Lindley","year":"2019","journal-title":"Scand J Immunol"},{"key":"66","doi-asserted-by":"publisher","first-page":"7958","DOI":"10.1093\/nar\/gkaa532","article-title":"Asymmetric dimerization of adenosine deaminase acting on RNA facilitates substrate recognition","volume":"4","author":"Beal","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"67","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.molcel.2017.12.010","article-title":"The Antiviral and Cancer Genomic DNA Deaminase APOBEC3H Is Regulated by an RNA-Mediated Dimerization Mechanism","volume":"6","author":"Harris","year":"2018","journal-title":"Mol Cell"},{"key":"68","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.sbi.2020.12.004","article-title":"Interactions of APOBEC3s with DNA and RNA","volume":"6","author":"Matsuo","year":"2021","journal-title":"Curr Opin Struct Biol"},{"key":"69","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Goldberg","year":"2012","journal-title":"Cancer Discov"},{"key":"70","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Schultz","year":"2013","journal-title":"Sci Signal"},{"key":"71","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v028.i05","article-title":"Building Predictive Models in R Using the caret Package","volume":"2","author":"Kuhn","year":"2008","journal-title":"J Stat Softw"},{"key":"72","first-page":"1","article-title":"mlr: Machine Learning in R","volume":"1","author":"Jones","year":"2016","journal-title":"J Mach Learn Res"},{"key":"73","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.21105\/joss.01686","article-title":"Welcome to the Tidyverse","volume":"4","author":"Miller","year":"2019","journal-title":"J Open Source Softw"},{"key":"74","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"3","author":"Koch","year":"1977","journal-title":"Biometrics"},{"key":"75","unstructured":"Therneau. A Package for Survival Analysis in R. 2020. https:\/\/CRAN.R-project.org\/package=survival."}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.27934","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T15:24:25Z","timestamp":1618327465000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.27934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,13]]},"references-count":75,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,4,13]]}},"alternative-id":["27934"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.27934","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,13]]}}}